Abeona Therapeutics Inc.
A developer of gene and cell therapies for rare, life-threatening diseases. Its first approved treatment, ZEVASKYN, uses a patient's own skin cells to heal the painful, hard-to-close wounds of recessive dystrophic epidermolysis bullosa, a disorder that gives children skin so fragile they're called "butterfly children." The company, formerly named PlasmaTech Biopharmaceuticals, took the name Abeona from the Roman goddess who protects children, reflecting its focus on young patients with serious genetic conditions.
Bought 250.0K
Sold 1.00M
Sold 345.5K
Granted 2.11M · Bought 50.0K · Sold 370.8K
Granted 300.0K · Bought 62.5K
Granted 533.6K
Granted 873.3K · Bought 11.1K · Sold 137.5K
Granted 450.0K · Bought 43.2K
Granted 631.9K · Bought 25.0K · Sold 131.4K
Granted 491.2K · Sold 91.0K
Granted 76.6K · Sold 27.8K
Bought 601.6K · Sold 173.1K
Granted 18.0K · Bought 270.0K
Granted 200.0K
Granted 630.9K · Sold 98.3K
Granted 258.1K · Bought 7.5K · Sold 19.1K
Granted 258.1K · Bought 11.0K · Sold 25.3K
Granted 258.1K · Sold 20.0K
Granted 299.5K · Sold 83.5K
Granted 100.0K
Granted 93.3K · Bought 4.0K
Granted 90.0K
Granted 84.5K
Granted 333.1K · Sold 163.3K
Granted 38.0K
Granted 84.5K · Sold 47.1K
Granted 35.9K
Granted 32.8K
Granted 15.0K
Granted 1.35M · Bought 25.0K · Sold 717.6K
Granted 948.5K · Sold 286.8K
Bought 6.0K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Beach Capital LLC +2 co-filers10% owner, Director, 10% owner · 14 transactions | — | 13.23Mas of Dec 2014 | — | 250.0K | — |
| Rouhandeh Steven H +1 co-filerDirector, 10% owner · 16 transactions | — | 11.08Mas of May 2021 | — | — | 1.00M |
| Venkatesan Jay +3 co-filers10% owner · 4 transactions | — | 5.17Mas of Jun 2012 | — | — | 345.5K |
| Seshadri VishwasChief Executive Officer, Director · 32 transactions | — | 1.37M | 2.11M | 50.0K | 370.8K |
| Jeffrey B DavisCheif Operating Officer, Director · 8 transactions | — | 1.33Mas of May 2015 | 300.0K | 62.5K | — |
| Rouhandeh Steven HDirector, 10% owner · 3 transactions | — | 533.6Kas of May 2021 | 533.6K | — | — |
| Vazzano Joseph WalterChief Financial Officer · 30 transactions | — | 518.4K | 873.3K | 11.1K | 137.5K |
| Ahn Mark JDirector · 4 transactions | — | 493.2Kas of Nov 2016 | 450.0K | 43.2K | — |
| O'Malley Brendan M.SVP, Chief Legal Officer · 33 transactions | — | 440.0K | 631.9K | 25.0K | 131.4K |
| Carr EdwardChief Financial Officer · 9 transactions | — | 400.2Kas of Oct 2021 | 491.2K | — | 91.0K |
| Vasanthavada MadhavChief Commercial Officer · 6 transactions | — | 303.2K | 76.6K | — | 27.8K |
| Feinberg Larry N +4 co-filers10% owner · 27 transactions | — | 296.5Kas of Feb 2008 | — | 601.6K | 173.1K |
| Buono StefanoDirector · 4 transactions | — | 288.0Kas of May 2020 | 18.0K | 270.0K | — |
| Luci David PDirector · 5 transactions | — | 263.2Kas of Jun 2009 | 200.0K | — | — |
| Amoroso MichaelDirector · 15 transactions | — | 217.8K | 630.9K | — | 98.3K |
| Charles Faith L.Director · 10 transactions | — | 176.4K | 258.1K | 7.5K | 19.1K |
| Alland LeilaDirector · 10 transactions | — | 173.6K | 258.1K | 11.0K | 25.3K |
| Wuchterl Donald A.Director · 9 transactions | — | 167.9K | 258.1K | — | 20.0K |
| Silverstein Christine BerniDirector · 13 transactions | — | 119.6K | 299.5K | — | 83.5K |
| Siffert Joao MDChief Executive Officer, Director · 1 transaction | — | 100.0Kas of May 2020 | 100.0K | — | — |
| Howell Stephen B.Director · 4 transactions | — | 97.5Kas of May 2020 | 93.3K | 4.0K | — |
| Thompson Stephen BVP-Finance Chief Acctg Officer · 2 transactions | — | 84.9Kas of May 2015 | 90.0K | — | — |
| Zeiher Bernhardt GDirector · 3 transactions | — | 84.5K | 84.5K | — | — |
| Alvino MarkDirector · 24 transactions | — | 77.1K | 333.1K | — | 163.3K |
| Migausky George VDirector · 1 transaction | — | 38.0Kas of Jun 2020 | 38.0K | — | — |
| Crombez EricDirector · 6 transactions | — | 37.3K | 84.5K | — | 47.1K |
| Tomasello ShawnDirector · 1 transaction | — | 35.9Kas of May 2020 | 35.9K | — | — |
| Goldan Keith A.Director · 1 transaction | — | 32.8K | 32.8K | — | — |
| Nowotnik David PSr. VP R&D · 1 transaction | — | 20.1Kas of Jan 2012 | 15.0K | — | — |
| Wider ToddDirector · 25 transactions | — | 16.9Kas of Sep 2022 | 1.35M | 25.0K | 717.6K |
| Mann Paul ElliotDirector · 12 transactions | — | 16.9Kas of Sep 2022 | 948.5K | — | 286.8K |
| Van Duyne Richard BDirector · 1 transaction | — | 6.0Kas of Apr 2019 | — | 6.0K | — |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over all recorded history: -2.37M shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.